Yosuke Oikawa
R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan
- Papers in database
- 4
- Years active
- 2017 – 2020
- Health outcomes studied
- 1
Health Outcomes Studied
Papers (4)
- 2020The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin10.1080/19490976.2020.1758290
- 2018Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis10.12938/bmfh.18-020
- 2018Effect of probiotic Bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats10.1038/s41598-018-30943-3
- 2017Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors10.1371/journal.pone.0173979